Latest news
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Given Average Rating of "Buy" by Brokerages - MarketBeatMarketBeat · Sat, 08 Aug 2026 06:17:04 GMTQ2 2026 CytomX Therapeutics Inc Earnings Call Transcript - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:27:34 GMTCytomX Therapeutics (NASDAQ:CTMX) Announces Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTCytomX Therapeutics (CTMX) Stock Faces Revenue Collapse As Pipeline Hopes Carry The Story - simplywall.stsimplywall.st · Sat, 08 Aug 2026 02:30:50 GMTState Street Corporation (CTMX) reports 5.4% beneficial stake in CytomX Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 13:21:14 GMTCytomX Therapeutics Inc (CTMX) (Q2 2026) Earnings Call Highlights: Varetta M Advances Toward ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:03:00 GMTCytomX Therapeutics secures $37M from Regeneron amid Q2 revenue miss - scanx.tradescanx.trade · Fri, 07 Aug 2026 02:21:26 GMTCytomX Therapeutics Q2 Earnings Call Highlights - TradingViewTradingView · Fri, 07 Aug 2026 01:03:00 GMT